Patent details
EP3337478 Title: DRUG COMBINATION COMPRISING LIPOSOMAL IRINOTECAN, OXALIPLATIN, 5-FLUOROURACIL AND LEUCOVORIN FOR TREATING METASTATIC PANCREATIC CANCER
Basic Information
- Publication number:
- EP3337478
- PCT Application Number:
- US2016047727
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP167583376
- PCT Publication Number:
- WO2017034957
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- DRUG COMBINATION COMPRISING LIPOSOMAL IRINOTECAN, OXALIPLATIN, 5-FLUOROURACIL AND LEUCOVORIN FOR TREATING METASTATIC PANCREATIC CANCER
- French Title of Invention:
- COMBINAISON DE MÉDICAMENTS RENFERMANT DE L'IRINOTÉCAN LIPOSOMAL, DE L'OXALIPLATIN, DU 5-FLUOROURACILE ET DE LA LEUCOVORINE POUR LE TRAITEMENT DU CANCER PANCRÉATIQUE MÉTASTATIQUE
- German Title of Invention:
- ARZNEIMITTELKOMBINATION ENTHALTEND LIPOSOMALES IRINOTECAN, OXALIPLATIN, 5-FLUOROURACIL UND LEUCOVORIN ZUR BEHANDLUNG VON METASTASIERENDEM PANKREASKREBS
- SPC Number:
Dates
- Filing date:
- 19/08/2016
- Grant date:
- 12/08/2020
- EP Publication Date:
- 27/06/2018
- PCT Publication Date:
- 02/03/2017
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 12/08/2020
- EP B1 Publication Date:
- 12/08/2020
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 19/08/2036
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 05/08/2020
- Name:
- Ipsen Biopharm Ltd.
- Address:
- Ash Road, Wrexham Industrial Estate Wrexham LL13 9UF, United Kingdom (GB)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 17/08/2020
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- HENDRIKS, Bart, S.
- Address:
- United States (US)
2
- Name:
- KALRA, Ashish
- Address:
- United States (US)
3
- Name:
- BLANCHETTE, Sarah, F.
- Address:
- United States (US)
4
- Name:
- BAYEVER, Eliel
- Address:
- United States (US)
5
- Name:
- GADDY, Daniel, F.
- Address:
- United States (US)
6
- Name:
- LEE, Helen
- Address:
- United States (US)
7
- Name:
- FITZGERALD, Jonathan, Basil
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201562208209 P
- Priority Date:
- 21/08/2015
- Priority Country:
- United States (US)
2
- Priority Number:
- 201562216736 P
- Priority Date:
- 10/09/2015
- Priority Country:
- United States (US)
3
- Priority Number:
- 201562273244 P
- Priority Date:
- 30/12/2015
- Priority Country:
- United States (US)
4
- Priority Number:
- 201662281473 P
- Priority Date:
- 21/01/2016
- Priority Country:
- United States (US)
5
- Priority Number:
- 201662302341 P
- Priority Date:
- 02/03/2016
- Priority Country:
- United States (US)
6
- Priority Number:
- 201662323245 P
- Priority Date:
- 15/04/2016
- Priority Country:
- United States (US)
7
- Priority Number:
- 201662343313 P
- Priority Date:
- 31/05/2016
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 9/127; A61K 31/282; A61K 31/436; A61K 31/4745; A61K 31/475; A61K 31/513; A61K 31/519; A61P 35/04;
Publication
European Patent Bulletin
1
- Issue number:
- 202033
- Publication date:
- 12/08/2020
- Description:
- Grant (B1)
2
- Issue number:
- 202123
- Publication date:
- 09/06/2021
- Description:
- Opposition procedure started
3
- Issue number:
- 202038
- Publication date:
- 16/09/2020
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
Annual Fees
- Annual Fee Due Date:
- 01/09/2025
- Annual Fee Number:
- 10
- Annual Fee Amount:
- 131 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 14/08/2024
- Last Annual Fee Paid Number:
- 9
- Last Annual Fee Paid Amount:
- 115 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|---|---|
| 17/08/2020 | Power Of Attorney | 1 |
| 17/08/2020 | Outgoing Correspondence | 1 |